Mackenzie Financial
CRBU icon

Mackenzie Financial’s Caribou Biosciences CRBU Stock Holding History

Mackenzie Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.43M Buy
3,650,796
+2,708,010
+287% +$5.35M 0.01% 770
2026
Q1 		$1.79M Buy
+942,786
New +$1.62M ﹤0.01% 953

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mackenzie Financial's CRBU Position: Q2 2026 in Review

Mackenzie Financial increased its Caribou Biosciences (CRBU) stake by 287% in Q2 2026, buying an estimated $5.35M and bringing the position to 3,650,796 shares worth $6.43M. The position accounts for 0.01% of the portfolio, ranked #770.

Mackenzie Financial first reported a position in CRBU in Q1 2026 and has held it in 2 quarters since. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Mackenzie Financial held 3,650,796 shares of Caribou Biosciences worth $6.43M as of Q2 2026.
  • Mackenzie Financial bought 2,708,010 Caribou Biosciences shares in Q2 2026, an estimated $5.35M.
  • Caribou Biosciences made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #770 holding.
  • Mackenzie Financial first reported a position in Caribou Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.